Tuesday, February 23, 2016

Management of Antibiotic Induced Thrombocytopenia

General
  • platelet counts between 100 and 150 × 109/L do not necessarily indicate disease if they have been stable for more than 6 months,2 and the adoption of a cutoff value of 100 × 109/L may be more appropriate to identify a pathologic condition
  • Antibiotic-induced thrombocytopenia presents a particularly thorny dilemma in which the dual problems of infection and antibiotic-induced bleeding risk must be effectively balanced
  • published reports regarding antimicrobial-induced thrombocytopenia describes decreasing platelet count and development of thrombocytopenia within 4 days after exposure to ciprofloxacin and piperacillin/tazobactam consistent
  • most episodes of thrombocytopenia among critically ill patients appears to be driven by other factors than antimicrobials, especially underlying severe infection.


Evidence from Study:
  • single center observational cohort study at an urban community teaching hospital seeking to compare the risk of hemorrhage associated mortality with that of non-hemorrhage associated mortality in antibiotic-induced thrombocytopenia.
  • Mortality is considered hemorrhage associated if an active bleed is noted within one week prior to death.
  • Thrombocytopenia is classified as mild, moderate, or severe depending on platelet nadir: “mild” is a decline to <150,000/µL, “moderate” is a decline to <50,000/µL, and “severe” is a decline to <20,000/µL.
  • To qualify as antibiotic-induced, the platelet reduction must have begun between two and ten days after antibiotic induction (Visentin et al Hematology/Oncology Clinics of North America 2008)
Evidence of Risk
  • A cut-off of 20% was chosen in order to include as many patients as possible for these analyses and at
  • the same time avoid that a decrease in platelet count was due to measurement variability.
  • found that that a 20% decrease in platelet count was associated with 28-day mortality; Threequarters
  • of patients with relative thrombocytopenia never reached a platelet count 100 x 109/L but still retained a 71% increased risk of death if the episode occurred within day 1-4 after study entry.
  • Therefore, this finding suggest that platelet count decrease influence prognosis in critically ill patients even when the threshold for absolute thrombocytopenia is never reached
Conclusion:
  • Antibiotic-managed patients who develop thrombocytopenia would appear to be at greater risk of death from non-hemorrhagic causes, particularly sepsis complications, than from hemorrhagic causes.
  • Absent a severely low platelet count, history of bleed, and/or active bleed, a patient may benefit more from continuing with effective antibiotics--even putatively thrombocytopenic antibiotics--than from discontinuing them or substituting them for suboptimal antibiotics
Reference:
  1. Hemorrhage Risk in Antibiotic-Induced Thrombocytopenia: Rethinking Priorities. Blood Dec 2014, 124 (21) 2786
  2. The Potential of Antimicrobials to Induce Thrombocytopenia in Critically Ill Patients: Data from a Randomized Controlled Trial. November 28, 2013

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.